To Advise the Company’s Mitral Transcatheter Edge-to-edge Repair Project and the Company in General SUZHOU, China, Sept. 6, 2021 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce Saibal Kar MD, FACC, FSCAI, board-certified interventional cardiologist has agreed to become our exclusive consultant in China to advise the research and development of our Mitral Transcatheter […]
Tag: Peijia Medical
Peijia Medical Brings China into the “Recoverable Era” with its TAVR Products
– Peijia Medical takes China into the “Recoverable Era” with its TAVR products featuring a second-generation transcatheter aortic valve replacement system approved for commercialization SUZHOU, China , June 28, 2021 / PRNewswire / – The TaurusElite ® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusElite ® “) and which has been developed by Peijia Medical (9996. HK) It […]
Peijia Medical’s Jasper® SS Detachable Coil Receives NMPA Approval for Commercialization
SUZHOU, China, June 24, 2021 /PRNewswire/ — On June 15, 2021, Jasper® SS—a new detachable coil independently developed by Achieva Medical, subsidiary of Peijia Medical (9996.HK)—was approved by the National Medical Products Administration (“NMPA”) for commercialization (registration number GXZZ 20113130440). In the field of neurointervention, embolization coils are designed to be as thin as […]
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product
SUZHOU, China, June 9, 2021 /PRNewswire/ — Peijia Medical (HKEX:9996, or “Peijia“), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based medical technology incubator, to explore innovative solutions for Structural Heart Disease. This partnership includes Peijia’s acquisition of a transcatheter tricuspid replacement technology (“TTVR”, or “inQB8 TTVR”) from inQB8, which is currently in […]
Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation
SUZHOU, China, June 4, 2021 /PRNewswire/ — Peijia Medical Limited signed a memorandum of strategic cooperation with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. on June 2. Going forward, the two parties will collaborate intensively on the commercialization of TAVR products, ultimately providing more Chinese medical staff and patients with better quality […]
Peijia Medical’s TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization
SUZHOU, China, April 24, 2021 /PRNewswire/ — A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusOne®“) developed by Peijia Medical (Suzhou) Co., Ltd., located in Suzhou Industrial Park, Jiangsu Province, was officially approved for commercialization […]
Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China
Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife’s Technology SUZHOU, China and PARIS, Dec. 20, 2020 /PRNewswire/ — Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, a Paris-based medical device company, focused on the development of a unique transeptal mitral valve replacement (“TMVR”) system to treat […]
Recent
4C Medical Secures $175M Series D Preferred Stock Financing
ZyVersa Therapeutics Highlights Data Demonstrating NLRP3 Inflammasome Inhibition Reduces Inflammation, Improves Heart Function, and Restores Glucose Homeostasis and Insulin Sensitivity in Obese Animal Model of Heart Failure (HFpEF) and Type 2 Diabetes
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion
Popular
- No commented posts yet